Patient Association: International Neuroendocrine Cancer Alliance (European Union): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 31: | Line 31: | ||
<span style="display:none">Pancreas</span> | <span style="display:none">Pancreas</span> | ||
<span style="display:none">Thymus gland</span> | <span style="display:none">Thymus gland</span> | ||
<span style="display:none">isPatientAssociation</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | <span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | ||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | <span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | ||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | <span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none"> | <span style="display:none">Esophageal</span> | ||
<span style="display:none"> | <span style="display:none">Gastric</span> | ||
<span style="display:none"> | <span style="display:none">Intestinal</span> | ||
<span style="display:none"> | <span style="display:none">Bowel</span> | ||
<span style="display:none"> | <span style="display:none">Colorectal</span> | ||
<span style="display:none"> | <span style="display:none">Appendix</span> | ||
<span style="display:none"> | <span style="display:none">Appendiceal</span> | ||
<span style="display:none"> | <span style="display:none">Duodenum</span> | ||
<span style="display:none"> | <span style="display:none">Jejunum</span> | ||
<span style="display:none"> | <span style="display:none">Ileum</span> | ||
<span style="display:none"> | <span style="display:none">Anal</span> | ||
<span style="display:none"> | <span style="display:none">Perianal</span> | ||
<span style="display:none"> | <span style="display:none">Hepatic</span> | ||
<span style="display:none"> | <span style="display:none">Biliary</span> | ||
<span style="display:none"> | <span style="display:none">Hepatobiliary</span> | ||
<span style="display:none"> | <span style="display:none">Endocrine</span> | ||
Latest revision as of 12:06, 14 December 2025
Go back to European Union page
Primary purpose: To advocate globally for patients with neuroendocrine cancer and genetic neuroendocrine tumours (NETs) by raising awareness, promoting scientific advancements, and fostering collaboration to ensure timely diagnosis, optimal treatment, support, and care.
Cancer areas of interest: C15-C26: Digestive system cancers, C30-C39: Lung/chest cancers and C73-C75: Thyroid and other gland cancers.
Access to information: Click here to access.
